MSCs utilized in coronavirus treatment show promising results

Researchers have published the results of patients treated with mesenchymal stem cells following coronavirus infection. In research making global headlines, clinicians from YouAn Hospital (Beijing, China) have collaborated with Kulin Jin, a researcher at the University of North Texas Health Science Center (TX, USA), to treat seven patients with mesenchymal stem cells after they were severely affected by COVID-19.  The work was recently described in Aging and Disease, and, if substantiated by further trials, the treatment could offer a method of reducing the damage caused by the global pandemic. The concept behind the therapy sees mesenchymal stem cells utilizing their...